Proceedings of the National Academy of Sciences · 2001 · 583 citations · 34 references
MedicineDevelopmental BiologyOphthalmologyDevelopmental SignalingOcular DiseasePediatric OphthalmologyAngiogenesisGrowth Factor SignalingOcular DevelopmentRetinal DevelopmentRetinal Vascular DiseaseRetinopathy Of PrematurityInsulin-like Growth Factor 1 DeficiencyInsulin-like Growth Factor DeficiencyInsulin-like Growth Factor-1NeovascularizationOcular Vascular DevelopmentProtein Kinase B SignalingVascular Endothelial Growth FactorVascular Growth
Retinopathy of prematurity is a blinding disease, initiated by lack of retinal vascular growth after premature birth. We show that lack of insulin-like growth factor I (IGF-I) in knockout mice prevents normal retinal vascular growth, despite the presence of vascular endothelial growth factor, important to vessel development. In vitro, low levels of IGF-I prevent vascular endothelial growth factor-induced activation of protein kinase B (Akt), a kinase critical for endothelial cell survival. Our results from studies in premature infants suggest that if the IGF-I level is sufficient after birth, normal vessel development occurs and retinopathy of prematurity does not develop. When IGF-I is persistently low, vessels cease to grow, maturing avascular retina becomes hypoxic and vascular endothelial growth factor accumulates in the vitreous. As IGF-I increases to a critical level, retinal neovascularization is triggered. These data indicate that serum IGF-I levels in premature infants can predict which infants will develop retinopathy of prematurity and further suggests that early restoration of IGF-I in premature infants to normal levels could prevent this disease.
34
Hans-Peter Gerber, Amy E. McMurtrey, Joe Kowalski et al. · Journal of Biological Chemistry · 1998 · 2K citations · Full text